ZY Investments, a Chinese healthcare-focused private equity fund headquartered in Beijing, has teamed up with Sundiro Holding, a motorcycle manufacturing and coal mining company located in Hainan province, to establish a $473 million healthcare investment fund. The new fund intends to invest in private Chinese healthcare companies. The goal will be to use M&A to consolidate the companies and/or to restructure the assets of its portfolio companies. Genexine (KOSDAQ, 095700), a South Korean novel drug developer, out-licensed China rights to three clinical or near-clinical stage biologic drug candidates to Tasly Pharma (SHA: 600535) of Tianjin in a deal worth up...